By Dani Blum The Food and Drug Administration on Tuesday approved Ozempic to reduce the risk of serious complications in people who have both Type 2 diabetes and chronic kidney disease.

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with ...

By Dana G. Smith and Dani Blum Over a decade ago, a smattering of studies suggested that early cousins of drugs like Ozempic and Mounjaro could prevent, or even reverse, signs of Alzheimer’s ...

Weight-loss drugs such as Ozempic have been a breakthrough because they eliminate the need to cut back or compensate by mimicking the gut hormone (GLP-1) and making people feel full faster.

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications ... The dose may be further increased to 1.8 mg daily if needed.